109764-50-3

Upstream product

• 109890-16-6 4-(1,4,5,6-tetrahydro-6-oxo-3-pyridazinyl)benzenecarbothioamide 
• 36725-21-0 4-(6-oxo-1,4,5,6-tetrahydropyridazin-3-yl)benzonitrile 
• 109890-17-7 6-<4-(4,5-dihydro-1H-imidazol-2-yl)phenyl>-4,5-dihydro-3(2H)-pyridazinone 

Relevant academic research and scientific papers

Cardiotonic agents. 7. Inhibition of separated forms of cyclic nucleotide phosphodiesterase from guinea pig cardiac muscle by 4,5-dihydro-6-[4-(1H-imidazol-1-yl)phenyl]-3(2H)-pyridazinones and related compounds. Structure-activity relationships and correl

The structure-activity relationships of a series of 4,5-dihydro-6-[4-(1H-imidazol-1-yl)phenyl]-3(2H)-pyridazinones and related compounds were investigated for the in vivo inhibition of different forms of cyclic nucleotide phosphodiesterase (PDE) isolated